Bonraybio CoTPE:6955 65 Days Payable is 13.33 as of Dec. 2025, which is 56% below its 10-year median of 30.28. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Bonraybio Co ranks worse than 93.46% on this metric.
The historical rank and industry rank for Bonraybio Co's Days Payable or its related term are showing as below:
TPE:6955'
s Days Payable Range Over the Past 10 Years
Min: 16.94 Med: 30.28 Max: 38.74
Current: 20.33
During the past 6 years, Bonraybio Co's highest Days Payable was 38.74. The lowest was 16.94. And the median was 30.28.
TPE:6955's Days Payable is ranked worse than 93.46% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs TPE:6955: 20.33
Bonraybio Co's Days Payable
declined
from Dec. 2024 (19.49) to Dec. 2025 (13.33).
It may suggest that Bonraybio Coaccelerated paying its suppliers.
Bonraybio Co Days Payable Related Terms
Bonraybio Co Days Payable Historical Data
* Premium members only.
The historical data trend for Bonraybio Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6955 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Bonraybio Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonraybio Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Bonraybio Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bonraybio Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonraybio Co (TPE:6955) has a Days Payable of 13.33 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonraybio Co and its competitors. This is 56% below median its historical median of 30.28. Over the past decade, Bonraybio Co's Days Payable has ranged from 16.94 to 38.74. According to the industry distribution chart, Bonraybio Co ranks #743 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 93.5%.
Is Bonraybio Co's Days Payable too high?
Bonraybio Co's current Days Payable of 13.33 is 56% below median its 10-year median of 30.28. Over the past 10 years, this metric has ranged from a low of 16.94 to a high of 38.74. The Medical Devices & Instruments industry median Days Payable is 68.07. Bonraybio Co's value of 13.33 is 80.4% below this industry median. Based on the distribution chart, Bonraybio Co ranks #743 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bonraybio Co ranks #743 out of 795 companies for Days Payable. This places Bonraybio Co in the lower half of its industry. The industry median Days Payable is 68.07. Bonraybio Co's value of 13.33 is 80.4% below this benchmark. Historically, Bonraybio Co's own Days Payable has ranged from 16.94 to 38.74 over the past decade. While the company's 10-year median is 30.28 vs. the industry median of 68.07, Bonraybio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bonraybio Co's current Days Payable of 13.33 is 80.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bonraybio Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonraybio Co's current Days Payable is 13.33, which is 56% below median its own 10-year median of 30.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.50 — trading 34.8% below its estimated fair value. The current Days Payable is 13.33, which is 56% below median its 10-year median of 30.28 and 80.4% below the Medical Devices & Instruments industry median of 68.07. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current Days Payable is 13.33 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bonraybio Co (TPE:6955) Overvalued in 2026?
Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued.
The current stock price of NT$120.50 is trading 34.8% below its estimated GF Value™ of NT$184.74.
GuruFocus considers Bonraybio Co to be Possible Value Trap.
Key valuation signals for TPE:6955:
Days Payable: 13.33 (56% below median its 10-year median of 30.28)
GF Value™: NT$184.74 vs. price of NT$120.50 (34.8% below fair value)
Industry Position: 80.4% below the Medical Devices & Instruments median (#743 of 795)
No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score
Get the complete analysis for TPE:6955
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6955 has been successfully added to your 
